Pharmacoepidemiology and Drug Safety, Certificate | Part time online | Utrecht University | Netherlands
Certificate Online

Pharmacoepidemiology and Drug Safety

21 days
1030 EUR/full
1030 EUR/full
Tuition fee
Apply date
Start date


During this Pharmacoepidemiology and Drug Safety course from Utrecht University, you will learn about typical problems, (such as confounding by indication, or rare side effects) and various pharmacoepidemiologic approaches to dealing with these problems.


Key facts

  • Pharmacoepidemiology and drug safety: a current issue. With the prospect that even more innovative drug therapies will be introduced in the coming years, society is demanding new approaches to comparative risk/benefit evaluation, as well as new concepts. Such evaluations are usually carried out only once the relevant therapies have been used widely in daily practice.
  • The safety and risk management assessment of different drug therapies is then performed within the framework of observational epidemiological studies (e.g. to establish proof of 'safety' and proof of 'effectiveness'). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drug's 'efficacy'.
  • The Pharmacoepidemiology and Drug Safety course from Utrecht University will cover key issues in pharmacoepidemiologic and drug safety research. Special topics you will discuss include adjustment for confounding, risk detection and management, molecular pharmacoepidemiology and public health. 
  • To succesfully participate in this course you will need a medical education, or a degree in biomedical or life sciences.


  • By the end of this pharmacoepidemiologic and drug safety course, you will be able to:
  • Broaden your understanding of pharmacological study design issues and methods
  • Explain confounding and other biases, including the indication-related methods of adjusting for confounding
  • Distinguish between different methods of drug safety research
  • Describe the principles of drug safety and risk management
  • Have an overview of the role of pharmacoepidemiological databases
  • Understand the essence of molecular pharmacoepidemiology
  • Have insight into drug utilization research

Programme Structure

Course Topics:

  • Cohort and case-control study designs;
  • Confounding and other biases;
  • Critical appraisal of publications;
  • Overview and application of pharmacoepidemiologic databases;
  • The future of electronic health record database research;
  • The value of individual patient observations in drug safety research;
  • Continuous evaluation of harm/benefit;
  • Molecular pharmacoepidemiology.

Key information


  • Part-time
    • 21 days
    • 14 hrs/week

Start dates & application deadlines




  • 1.5 ECTS credits



Academic requirements

We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.

English requirements

We are not aware of any English requirements for this programme.

Other requirements

General requirements

To enrol in this course, you need:

  • A BSc or Master’s degree in (Bio)medical or Life Sciences;
  • Preferably to already have taken the course Introduction to Epidemiology;
  •  Preferably to already have taken the course Study Design in Etiologic Research;
  • Preferably to already have taken the course Clinical Epidemiology;
  • Sufficient proficiency in English reading and writing.

Tuition Fee

To always see correct tuition fees
  • International

    1030 EUR/full
    Tuition Fee
    Based on the tuition of 1030 EUR for the full programme during 21 days.
  • EU/EEA

    1030 EUR/full
    Tuition Fee
    Based on the tuition of 1030 EUR for the full programme during 21 days.


Other interesting programmes for you

Our partners

Pharmacoepidemiology and Drug Safety
Utrecht University
Pharmacoepidemiology and Drug Safety
Utrecht University


Go to your profile page to get personalised recommendations!